Concerning NASH hepatocarcinogenesis, it is also important to mention the recently discovered novel potential prognostic biomarker of human NAFLD/NASH-HCC, sphingosine 1-phosphate receptor 2 (S1PR2) (Table 1 and Table 2). Here, S1PR2 is linked to metabolic dysfunction-associated steatotic liver disease.